We evaluated a new commercial latex agglutination test for herpes simplex virus antigen detection (Virogen Herpes Slide Test, Wampole Laboratories, Cranbury, N.J.). In testing of eluates from 100 lesion swabs, mostly from genital sites, the following test parameters were ascertained: sensitivity, 73%; specificity, 89%; positive predictive value, 89%; negative predictive value, 72%. Testing was also performed on 160 supernatants from 153 cell cultures inoculated with clinical samples. In this application, sensitivity and specificity were each 100%, provided supernatants were sampled for testing when the cytopathic effect involved at least 25% of the cell monolayer.
Latex agglutination is widely used for detection of bacterial and fungal antigens (2) but has received relatively limited application for detection of viral antigens (5) . Recently, a commercial latex agglutination test (Virogen Herpes Slide Test; Wampole Laboratories, Cranbury, N.J.) was developed to detect herpes simplex virus (HSV) antigen, both in selected clinical samples (vesicular and pustular lesions) and in culture supernatants from cell culture. We report here an evaluation of the Virogen latex agglutination test used for both of these applications.
(This material was presented in part at the 86th Annual Meeting of the American Society for Microbiology, Washington, D.C., 23-28 March 1986 .)
The specimens subjected to direct testing were 100 swabs of suspected herpetic lesions, mostly from genital sites of patients being evaluated for sexually transmitted diseases by Z.A.D. Lesions were swabbed by using rayon-tipped swabs (Viral Culturette; Marion Scientific, Div. Marion Laboratories, Inc., Kansas City, Mo.), and swabs were stored at 4°C until they were transported to the virology laboratory at Children's Hospital at Washington University Medical Center (usually within 24 h). Each lesion was described by the physician who obtained the specimen as vesicular, ulcerated, or other.
Upon receipt in the laboratory, swabs were eluted with 1.2 ml of Eagle minimal essential medium supplemented with 2% fetal bovine serum, penicillin (100 U/ml), streptomycin (100 p.g/ml), and amphotericin B (10 ,uglml), and one tube each of primary rabbit kidney and MRC-5 cells was inoculated with 0.25 ml of the eluate. The remaining eluate was stored at 4°C until it was used for latex agglutination. Cultures were incubated on roller drums at 36°C and examined for cytopathic effect daily for 7 days. All cultures exhibiting a cytopathic effect suggestive of HSV were confirmed and typed by fluorescent-antibody staining with monoclonal antibodies specific for HSV types 1 and 2 (Syva, Palo Alto, Calif.) (4) .
The latex agglutination test was performed as recommended by the manufacturer. The swab eluate was vortexed for 5 s and then centrifuged at 700 x g for 5 min. Fifty microliters of the supernatant was placed on each of two wells of a glass slide with 14-mm (diameter) ceramic rings. Ten microliters of pre-mixed specimen buffer absorbent was * Corresponding author. then added to each well, and the contents of each well were mixed with a disposable stirrer. The slide was then rotated on a slide rotator at 150 rpm for 5 min. After rotation, 10 ,ul of herpes reagent (latex particles coated with rabbit antibody to HSV) was added to one well and 10 ,ul of negative control latex (latex particles coated with rabbit antibody nonreactive with HSV) was added to the other well. The contents of each well were again mixed with a disposable stirrer, and the slide was rotated on a rotator for 25 min at 150 rpm. Immediately at 25 min, reactions were read by eye with light projected over a dark background. Reactions were considered positive if agglutination was 1+ (small but definite clumps against a cloudy background) or greater with the herpes latex and agglutination with the control latex was less than 1+. Positive and negative controls were tested with the herpes reagent and control latex with each run.
With this procedure, HSV antigen was detected in 41 (73%) of the 56 eluates that were culture positive for HSV and 5 (11%) of the 44 swab eluates that were culture negative for HSV (Table 1) . These results correspond to a sensitivity of 73% (41/56), a specificity of 89% (39/44), a positive predictive value of 89% (41/46), and a negative predictive value of 72% (39/54) in comparison with culture. As shown in Table 1 , there was a trend toward greater sensitivity in detecting HSV antigen in vesicular lesions (11/12) than in ulcerated lesions (21/28). This difference was not statistically significant (P > 0.05; Fisher exact test).
The latex agglutination test was also performed on 160 culture supernatants: 56 from the cultures described above that were positive for HSV plus 104 from 97 cultures of specimens routinely submitted for viral culture (7 cultures were sampled on two occasions, first when the cytopathic effect involved less than 25% of the monolayer and again when the cytopathic effect was more extensive). Of the 43 cultures negative for HSV by culture, 10 were positive for cytomegalovirus, 1 was positive for varicella-zoster virus, and 1 was positive for adenovirus. The culture types sampled included primary rabbit kidney, MRC-5, and African green monkey kidney. The culture type had no effect on the results of latex agglutination testing (data not shown).
To test culture supernatants, we removed them from the roller tube and centrifuged them at 700 x g for 5 min. Fifty microliters was added to each of two wells on the glass slide and tested by the above-described procedure. HSV antigen was detected in 110 (94%) of the 117 supernatants from Thus, Virogen performed very well for culture confirmation, achieving 100% sensitivity and specificity, provided that the cytopathic effect involved at least 25% of the monolayer at the time of testing. However, it performed less well for direct detection of HSV antigen, particularly with swabs from lesions that were other than purely vesicular, achieving an overall sensitivity of 73%. The overall specificity of 89% for direct testing reflects five culture-negative specimens that yielded positive latex agglutination tests. This study could not determine whether these five discrepancies represented false-negative cultures or false-positive latex agglutination tests. If the former is true, the specificity of Virogen would be higher than the 89% calculated here.
One previously published evaluation of the Virogen Herpes Slide Test by Halstead et al. found lower sensitivities than we did in our evaluation (49.7% for direct specimen testing and 75.7% for culture confirmation) (3). It is possible that differences in the stages of lesions tested contributed to the difference in sensitivity found by the two studies. This possibility cannot be further evaluated because the nature of the lesions tested in the Halstead study was not described. The lower sensitivity found when the test was used for culture confirmation is surprising, since we found that the test was 100% sensitive when used to test supernatants from cultures in which more than 25% of the monolayer was involved. It is possible that our cultures had a more advanced cytopathic effect when sampled for testing, although in most instances samples were removed from our cultures on the first day on which a cytopathic effect was detected.
A relative disadvantage inherent in using Virogen for culture confirmation is that in contrast to alternative available culture confirmation procedures, such as immunofluorescent-antibody staining (1, 4), Virogen does not distinguish between HSV types 1 and 2. Thus, if typing is required, an additional test must be performed. Otherwise, Virogen appears to be a reasonable alternative to immunofluorescentantibody staining for use in HSV culture confirmation. The relatively low sensitivity (73%) and negative predictive value (72%) of Virogen used as a direct specimen test indicate that Virogen should not be used to replace culture for the sensitive detection of HSV.
